October 26, 2016
Novartis CEO sees tougher U.S. drug pricing over next three-five years
Novartis expects a more difficult pricing environment for drugs in…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Severin Schwan
October 20, 2016
Roche sees sales growth, praises Tecentriq performance
The Swiss-based pharmaceutical major Roche has see a sales growth for the first three quarters of 2016, praising good performance of Tecentriq, it’s anti PD-L1 cancer immunotherapy that was approved for non-small cell lung cancerby the US FDA in May this year.
November 17, 2015
Roche breast cancer drug at centre of UK pricing row
A Roche drug that can prolong the lives of some women with advanced breast cancer has been plunged back into the centre of a drug pricing row after Britain’s health cost agency declared that it is still too expensive.